1. Product selection issues
Working group
Product selection issues

2. GF PSM Plans
Can the list of medicines be revised once PSM plans have been approved?
Introduction of OI drugs (SA)
revision of guidelines (EG)
latency period with needs in additional ARVs and before guidelines be up-dated
What is the process to get the approval from GF? LFA, PR, Port-Folio?

3. Condoms procurement requirements
Clarification needed on WB requirements (Tanzania)
How countries in the room have responded to WB requirements of a pre qualified list of manufacturers ?

4. ARV paediatrics
WHO Pre-qualified list: too few paediatric formulations (Uganda)
Not registered at country level

5. Other issues GF: notion of stringent authorities (SA)
Clinton Foundation: match between the pricing list and WHO pre-qualified list